Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial - Concepedia

Concepedia

Publication | Closed Access

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

340

Citations

21

References

2019

Year

David R. Matthews, Päivi M. Paldánius, Pieter Proot, YannTong Chiang, Michael Stümvoll, Stefano Del Prato

Diabetes ManagementDiabetesType 2Clinical TrialsEarly Combination TherapyDiabetes MellitusMedicineGlycaemic Durability

References

	Year	Citations

Page 1